Circulating tumour cells in metastatic head and neck cancers

International Journal of Cancer

Volumn 136, Issue 11, 2015, Pages 2515-2523

  Kulasinghe, Arutha ^a   Perry, Chris ^b   Jovanovic, Lidija ^c   Nelson, Colleen ^c   Punyadeera, Chamindie ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

circulating tumour cells; epithelial mesenchymal transition; Head and neck cancer; head and neck squamous cell carcinoma; microemboli

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; VIMENTIN; TUMOR MARKER;

BREAST METASTASIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL FATE; CELL SIZE; CIRCULATING TUMOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; METASTASIS; METASTATIC COLORECTAL CANCER; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; BLOOD; HEAD AND NECK TUMOR; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR EMBOLISM;

CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84924872349     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29108     Document Type: Review

References (87)

1. Bozec A, Peyrade F, Hebert C, et al. Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2013; 270: 2745-9.
2. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
3. Foundation OC,. Oral Cancer Facts, 2013. Available at: http://oralcancerfoundation.org/facts/index.htm.
4. Jatana KR, Teknos TN, Chalmers JJ, et al. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2010; 136: 1274-9.
5. Mockelmann N, Laban S, Pantel K, et al. Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up. Eur Arch Otorhinolaryngol 2014; 271: 15-21.
6. Allen CT, Law JH, Dunn GP, et al. Emerging insights into head and neck cancer metastasis. Head Neck 2013; 35: 1669-78.
7. Hristozova T, Tinhofer I, Konschak R, et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol 2011; 22: 1878-85.
8. Vermorken JB, Specenier P,. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 2010; 21: 252-61.
9. Bozec A, Peyrade F, Fischel J-L, et al. Emerging molecular targeted therapies in the treatment of head and neck cancer. Expert Opin Emerg Drugs 2009; 14: 299-310.
10. Takes RP, Shaha AR, Hartl DM, et al. Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol 2012; 48: 775-9.
11. Probert JC, Thompson RW, Bagshaw MA,. Patterns of spread of distant metastases in head and neck cancer. Cancer 1974; 33: 127-33.
12. Hong B, Zu Y,. Detecting circulating tumor cells: current challenges and new trends. Theranostics 2013; 3: 377-94.
13. Ferlito A, Shaha AR, Silver CE, et al. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 202-7.
14. Gorges TM, Pantel K,. Circulating tumor cells as therapy-related biomarkers in cancer patients. Cancer Immunol Immunother 2013; 62: 931-9.
15. Alix-Panabières C, Pantel K,. Circulating tumor cells: liquid biopsy of cancer. Clin chem 2013; 59: 110.
16. Joosse SA, Pantel K,. Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013; 73: 8-11.
17. Conteduca V, Zamarchi R, Rossi E, et al. Circulating tumor cells: utopia or reality? Future Oncol 2013; 9: 1337-52.
18. Chambers AF, Groom AC, MacDonald IC,. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72.
19. Pantel K, Alix-Panabières C,. Real-time liquid biopsy in cancer patients: fact or fiction? Cancer Res 2013; 73: 6384.
20. Hiltermann TJN, Kruyt FAE, Tissing H, et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol 2012; 23: 2937-42.
21. Rossi E, Barile C, Sava T, et al. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer 2012; 107: 1286-94.
22. Msaouel P, Koutsilieris M,. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis. BMC Cancer 2011; 11: 336.
23. Nichols AC, Hammond A, Palma DA, et al. Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system. Head Neck 2012; 34: 1440-4.
24. Rao C, Terstappen L, Bui T, et al. Circulating melanoma cells and survival in metastatic melanoma. Int J Oncol 2011; 38: 755-60.
25. Bidard FC, de Gramont A, Mariani P, et al. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2012; 82: 103-15.
26. Lianidou ES, Markou A,. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 2011; 57: 1242-55.
27. ASoCO(ASCO). Head and neck cancer, 2013. Available at: http://www.cancer.net/cancer-types/head-and-neck-cancer.
28. Globocan 2008. Estimated age-standardised incidence and mortality rates: both sexes, 2008. Available at: http://globocan.iarc.fr/.
29. Warnakulasuriya S,. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
30. Farris C, Petitte DM,. Head, neck, and oral cancer update. Home healthc Nurse 2013; 31: 322.
31. Elizabeth JF, Erika PR, Kermit LC, et al. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 735-9.
32. Hashibe M, Fernandez L, Wünsch-Filho V, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-89.
33. Pelucchi C, Gallus S, Garavello W, et al. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 2008; 17: 340-4.
34. Society AC,. What are the risk factors for oral cavity and oropharyngeal cancers?, 2013. Available at: http://www.cancer.org/cancer/oralcavityandoropharyngealcancer/detailedguide/oral-cavity-and-oropharyngeal-cancer-risk-factors.
35. Ovchinnikov DA, Cooper MA, Pandit P, et al. Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl Oncol 2012; 5: 321.
36. Pandit P, Cooper-White J, Punyadeera C,. High-yield RNA-extraction method for saliva. Clin Chem 2013; 59: 1118-22.
37. Schlecht NF, Franco EL, Pintos J, et al. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 1999; 10: 412-8.
38. Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35: 747-55.
39. Woods RSR, O'Regan EM, Kennedy S, et al. Role of human papillomavirus in oropharyngeal squamous cell carcinoma: a review. World J Clin Cases 2014; 2: 172-93.
40. Leemans CR, Braakhuis BJM, Brakenhoff RH,. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9.
41. Ragin CCR, Modugno F, Gollin SM,. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007; 86: 104-14.
42. Grover PK, Price TJ, Roberts-Thomson IC, et al. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol 2014.
43. Buglione M, Pasinetti N, Bolzoni A, et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival. Eur J Cancer 2012; 48: 3019-26.
44. Pantel K, Alix-Panabières C, Riethdorf S,. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6: 339-51.
45. Butler TP, Gullino PM,. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975; 35: 512-6.
46. Meng S, Euhus D, Haley B, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10: 8152-62.
47. Caixeiro NJ, Kienzle N, Lim SH, et al. Circulating tumour cells-a bona fide cause of metastatic cancer. Cancer Metast Rev 2014; 33: 747-56.
48. Vona G, Pol S, Bréchot C, et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004; 39: 792-7.
49. Molnar B, Ladanyi A, Tanko L, et al. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2001; 7: 4080-5.
50. Pantel K, Brakenhoff RH, Brandt B,. Detection, clinical relevance and specific biological properties of disseminating cancer cells in breast cancer patients. Nat Rev Cancer 2008; 8: 329-40.
51. Patriarca C, Macchi RM, Marschner AK, et al. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev 2012; 38: 68-75.
52. Balasubramanian P, Summers JTA, Lustberg MB, et al. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PloS one 2012; 7: e42048.
53. Park S, Ang RR, Duffy SP, et al. Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells. PloS one 2014; 9: e85264.
54. Cristofanilli M, Terstappen LWMM, Hayes DF, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
55. Klein CA,. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009; 9: 302-12.
56. Huvos AG, Hutter RV, Berg JW,. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971; 173: 44-6.
57. Zhang L, Riethdorf S, Wu G, et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res 2012; 18: 5701-10.
58. Kotwall C, Sako K, Razack MS, et al. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 1987; 154: 439-42.
59. Jäckel MC, Rausch H,. Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract. The effect of clinical tumor parameters and course of illness. HNO 1999; 47: 38.
60. Langley RR, Fidler IJ,. The seed and soil hypothesis revisited-the role f tumor-stroma interactions in metastasis to different organs. Int J Cancer 2011; 128: 2527-35.
61. Schwartz RA,. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33: 161-85.
62. Koch WM,. Axillary nodal metastases in head and neck cancer. Head Neck 1999; 21: 269-72.
63. Kim M-Y, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell 2009; 139: 1315-26.
64. Baum B, Settleman J, Quinlan MP,. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008; 19: 294-308.
65. Erpenbeck L, Schön MP,. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 2010; 115: 3427-36.
66. Gay LJ, Felding-Habermann B,. Platelets alter tumor cell attributes to propel metastasis: programming in transit. Cancer Cell 2011; 20: 553.
67. Liu Y, Jiang P, Capkova K, et al. Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res 2011; 71: 6492-502.
68. Borsig L, Wong R, Feramisco J, et al. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 2001; 98: 3352-7.
69. Karpatkin S, Pearlstein E, Salk PL, et al. Role of platelets in tumor cell metastases. Ann N Y Acad Sci 1981; 370: 101-18.
70. Camerer E, Qazi AA, Duong DN, et al. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004; 104: 397-401.
71. Karpatkin S, Pearlstein E, Ambrogio C, et al. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 1988; 81: 1012-9.
72. Zuo JH, Qu JQ, Chen Y, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011; 112: 2508-17.
73. Kupferman ME, Yu D, Myers JN, et al. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 2010; 29: 2047-59.
74. Maie ASJ, Saswati H, Li Z, et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 6018-27.
75. Bitting RL, Boominathan R, Rao C, et al. Development of a method to isolate circulating tumor cells using mesenchymal-based capture. Methods 2013; 64: 129-36.
76. He S, Li P, Long T, et al. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results. J Laryngol Otol 2013; 127: 788.
77. Tinhofer I, Hristozova T, Stromberger C, et al. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2011; 83: E685-E90.
78. Gröbe A, Pantel K, Riethdorf S, et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity. Clin Cancer Res 2014; 20: 425-33.
79. Riethdorf S, Fritsche H, Jackson S, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007; 13: 920-8.
80. Jatana KR, Lang JC, Chalmers JJ,. Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Future Oncol 2011; 7: 481-4.
81. de Albuquerque A, Kaul S, Breier G, et al. Multimarker analysis of circulating tumor cells in peripheral blood of metastatic breast cancer patients: a step forward in personalized medicine. Breast Care 2012; 7: 7-12.
82. Sarantou T, Chi DD, Garrison DA, et al. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997; 57: 1371-6.
83. Chen C, Zimmermann M, Tinhofer I, et al. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer lett 2013; 338: 47-56.
84. Valastyan S, Weinberg Robert A,. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-92.
85. Belbin TJ, Prystowsky MB, Schlecht NF, et al. Site-specific molecular signatures predict aggressive disease in HNSCC. Head Neck Pathol 2008; 2: 243-56.
86. Balasubramanian P, Yang L, Lang JC, et al. Confocal images of circulating tumour cells obtained using a methodology and technology that removes normal cells. Mol Pharm 2009; 5: 1402-8.
87. Yang L, Lang J, Balasubramanian P, et al. Optimization of an Enrichment process for Circulating tumor cells from the blood of Head and Neck Cancer patients through depletion of normal cells. Biotechnol Bioeng 2009; 102: 521-534.